2009 Speaker

Mara G. Aspinall
President and CEO, On-Q-Ity


Mara Aspinall is President and CEO of On-Q-ity, Inc., an innovative diagnostics company focused on informing and transforming cancer treatment cycle management, improving the quality of life for cancer patients.

For the last seven years, Mara was President of Genzyme Genetics, a leading provider of testing services in the oncology and reproductive markets. Under Mara's leadership, Genzyme Genetics set the standard for industry quality, exhibiting profitable company growth at an unprecedented pace. She transformed the business, expanding its scope and market reach to become one of the nation's largest diagnostic laboratories. The company successfully completed and integrated four acquisitions, expanded research and development, launched more than two dozen new products and initiated new programs for community outreach and education.


Mara has been on the Board of Predictive Biosciences since its inception, serving as Chairman for the past year. She is also a Board member of Blue Cross Blue Shield of Massachusetts. Mara is appointed as Lecturer in Health Care Policy at Harvard Medical School and will teach a seminar series on related topics. During 2008, Mara was on sabbatical from Genzyme working at HMS and Dana-Farber Cancer Institute on the implementation of personalized medicine into physician education, clinical practice and research.


Previously, Mara served as President of Genzyme Pharmaceuticals. She restructured the business from generic drug manufacturing to value-added custom production, while building a new international management team that created more than 25% annual profitable growth.
She is an active member of the Federal Secretary of Health and Human Services' Advisory Commission on Genetics, Health and Society as well as Vice Chairman of the Personalized Medicine Coalition. Most recently, she co-authored, Realizing the Promise of Personalized Medicine in Harvard Business Review.


Bain & Company, an international strategic consulting firm, was where Mara started her business career. She earned her Master of Business Administration from Harvard Business School and her undergraduate degree in International relations from Tufts University.

Back to Confirmed Speakers

"The Partnering for Cures conference provides a unique opportunity for leaders from business, philanthropy and nonprofits to come together to build partnerships to address the world's most challenging diseases. This type of cross-sector collaboration is critical to spurring innovation, mobilizing funds and shortening timelines to develop urgently needed drugs, vaccines and diagnostics for the prevention and treatment of high impact diseases."

- Dr. Seth Berkley, President & CEO, The International AIDS Vaccine Initiative

 
 
 
©2009 by Partnering for Cures  Terms Of Use  |  Privacy Statement